Abstract:Objective:To evaluate the effect of the expression of endothelial nitric oxide synthase(eNOS)on the capacity of the hepapic sinusoids by lipid-mediated eNOS gene transfer in cirrhotic rats.Methods:Ten of130male Sprague-Dawley rats were taken as normal controll group and the residual rats were induced to hepatic cirrhosis by intraperitoneal injection of carbon tetrachloride(CCl 4 ).Fourty cirrhotic rats were divided into four groups randomly:untreated group(n=10),eNOS-treated group(n=10),control plasmid-treated group(n=10)and Tris buffer-treated group(n=10).Liposome-eNOS was tansduced into rats of eNOS-treated group through the injection to portal vein;Tris buffer-treated group and control plasmid-treated group were received Tris buffer or control plasmid respectively.Five days later,the animals were sacrificed.Reverse Transcription-Polymerase Chain Reaction(RT-PCR)was performed to detect the expression of eNOS mRNA.Immunohistochemistry and image analysis were performed to detect the expression of eNOS and the capacity of liver sinusoid.The untreated cirrhotic group and normal controll group rats were killed,and the expression of eNOS and capacity of hepatic sinusoid were detected by the same method as described above.Results:①The content of eNOS and capacity of liver sinusoid in untreated cirrhotic group were(3.81±1.09)%and(3.51±0.72)%respectively,which were much lower than that of the normal group[(14.78±3.06)%and(9.32±1.05)%respectively](P0.01).The content of eNOS and the capacity of liver sinusoid were positively correlated in the both two groups,r=0.676(P0.05)and r=0.703(P0.05)respectively.②Five days after eNOS gene transfer,the expression of eNOS mRNA,content of eNOS and capacity of liver sinusoid were(1.22±0.14)U,(19.43±7.37)%and(5.77±1.49)%respectively,which were much higher than that in the control groups(P0.01).The expression of eNOS and the capacity of liver sinusoids were positively correlated in the all the cirrhotic rats treated with the3methods,r=0.799(P0.01),r=0.767(P0.01)and r=0.748(P0.05)respectively.Conclusions:The decreasing of eNOS caused by injury of the cirrhotic liver induces the constriction of the liver sinusoids.The production of eNOS increases remarkably after gene transfer which induces the relaxation of liver sinusoids by elevating the intrahepatic NO concentration.

Akt Gene Therapy for Cirrhotic Rats with Portal Hypertension

Effects of Ad-myr-HA-Akt on Cirrhotic Portal Hypertension in Rats

Vascular Endothelial Growth Factor Attenuates Hepatic Sinusoidal Capillarization in Thioacetamide-Induced Cirrhotic Rats

Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.

Construction of Recombinant Adenovirus Containing Akt and Its Expression in the Liver of Cirrhotic Rats

Angiogenesis Effect on Rat Liver after Administration of Expression Vector Encoding Vascular Endothelial Growth Factor D

[Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats]

Effects of Enos Gene Transfer on the Expression of Enos and Portal Hypertension in Cirrhotic Rats

The Effect on Liver Fibrosis and Portal Pressure after Administration of Expression Vector Encoding for Endothelial Growth Factor D in Biliary Cirrhotic Rats

Optimization of Adenovirus-Mediated Endothelial Nitric Oxide Synthase Delivery in Rat Hindlimb Ischemia

Induction of lymphocyte apoptosis in rat liver allograft by adenoviral gene transfection of human interleukin-10.

Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis.

Attenuation Of Experimental Liver Fibrosis By Hepatocyte Growth Factor Gene Delivery Mediated By Adenovirus

Effect of Enos Gene Transfer on the Capacity of Hepatic Sinusoids in cirrhotic rats

AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model

Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras

Experimental Investigation of Hepatic Arterial Embolism Treatment with Microsphere Encapsulation of Adenovirus with HSV-TK Gene

Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats

Adenoviral delivery of truncated MMP-8 fused with the hepatocyte growth factor mutant 1K1 ameliorates liver cirrhosis and promotes hepatocyte proliferation

Small Interfering RNA Targeting Connective Tissue Growth Factor Prevents Rats Liver Fibrosis

Treatment of Experimental Hepatic Fibrosis by Combinational Delivery of Urokinase‐type Plasminogen Activator and Hepatocyte Growth Factor Genes